Evaluation of oral keratinocyte progenitor and T-lymphocite cells response during early healing after augmentation of keratinized gingiva with a 3D collagen matrix - a pilot study by Darian Rusu et al.
RESEARCH ARTICLE Open Access
Evaluation of oral keratinocyte progenitor
and T-lymphocite cells response during
early healing after augmentation of
keratinized gingiva with a 3D collagen
matrix - a pilot study
Darian Rusu1, Bogdan Calenic2,3*, Maria Greabu2, Alexander Kralev1, Marius Boariu4, Florina Bojin5, Simona Anghel5,
Virgil Paunescu5, Octavia Vela6, Horia Calniceanu7 and Stefan-Ioan Stratul1
Abstract
Background: The aim of the present study is to analyze the behavior of selected populations of oral keratinocytes
and T-lymphocytes, responsible for re-constructing and maintaining the oral epithelial tissue architecture, following
augmentation of the keratinized oral mucosa using a 3D-collagen matrix.
Methods: Different groups of oral keratinocytes were isolated from biopsies harvested from 3 patients before the
surgical procedure, as well as 7 and 14 days after the augmentation procedure. T-lymphocytes were isolated from
peripheral blood at same timepoints. Keratinocytes were characterized for stem and differentiation markers, such
as p63, cytokeratin 10 and 14, and in vitro parameters, such as cell viability, cell size and colony-forming
efficiency. T-lymphocytes were analyzed for viability and the expression of various cluster of differentiation
markers. The methods included magnetic separation of cell populations, immunofluorescence, flow cytometry,
and histology of oral biopsies.
Results: Both at 7 and 14 days, the majority of cells that repopulate the matrix were actively
proliferating/progenitor oral keratinocytes with the phenotype integrin alfa6beta4 + CD71+. These cells display in
vitro characteristics similar to the progenitor cells analyzed before the matrix placement. T-lymphocytes
expressed CD8 and CD69 markers, while CD25 was absent.
Conclusion: The study shows that two weeks after the collagen membrane placement, the healing process
appeared to be histologically complete, with no abnormal immune response induced by the matrix, however,
with a higher than usual content of active proliferating cells, the majority of keratinocytes being characterized as
transit amplifying cells.
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Background
A healthy and functional mucogingival complex including
a band of keratinized gingiva is considered to be important
to ensure the underlying osseous stability around teeth
and implants [1]. Moreover, a lack of adequate keratinized
mucosa around dental implants is associated with more
plaque accumulation, tissue inflammation, mucosal reces-
sion as well as loss of attachment [2], therefore, soft tissue
augmentation procedures in clinical practice have been the
focus of increased attention recently. The rationale for per-
forming gingival augmentation procedures around natural
teeth and dental implants includes facilitating plaque con-
trol and improving patient comfort, in conjunction with
restorative, prosthetic or orthodontic procedures, and the
prevention of gingival recession [3]. The surgical approach
most frequently used for gingival augmentation is the api-
cally repositioned flap plus the application of an autogen-
ous free gingival graft or subepithelial connective tissue
graft harvested from the palatal mucosa [4].
Over the past decades, complete regeneration of the
oral mucosa following surgery has been the subject of
intense research and debate [5, 6]. In order to avoid
morbidities at the donor site, allograft materials, such as
acellular dermal matrix grafts and human fibroblast-
derived dermal substitutes, have also been used as an
alternative [7, 8]. Recently, a two-layer xenogeneic colla-
gen matrix has been used for augmenting keratinized tis-
sue around teeth and dental implants [1, 9, 10], while a
systematic review concluded that the apically positioned
flap/vestibuloplasty plus collagen matrix demonstrated
less gain in keratinized mucosa, but also less patient
morbidity and surgery time [11].
Prolonged healing times, limited functional and mech-
anical properties, immature basal lamina and poor an-
choring areas still need to be addressed when discussing
grafting procedures of oral mucosa [12]. Re-epithelization
following trauma or surgery represents an essential
process that is initiated by oral keratinocytes situated
around the wound, which are activated by a variety of sig-
nal molecules and start migrating to the wound site [13].
Previous experimental models show that activation of the
immune system and especially T-lymphocytes (TL) repre-
sents a requirement for the optimal healing following
wounds or surgery in the oral cavity [11].
The epithelia consist of several layers of keratinocytes
that have different characteristics. For detailed discus-
sions on keratinocyte cells and their specific roles, sev-
eral comprehensive reviews are available [14–20]. The
general architecture of the oral epithelium includes oral
keratinocyte stem cells found close to the basal mem-
brane, and to the blood vessels of the lamina propria.
These cells possess several attributes that clearly distin-
guish them from other oral keratinocytes: self renewal
potential, ability to differentiate into other cell types
from the same tissue, quiescence and a long life span.
They divide asymmetrically and give rise to progenitor
cells called “transit amplifying (TA) cells” that are ac-
tively proliferating cells and migrate from the lower
suprabasal layers to the upper ones. Previous studies show
that the proportion of progenitor cells in the mammalian
epithelium varies from 1 % [21] to 15–20 % [22–24]. Spe-
cifically, in oral epithelia, the percentage of progenitor
cells is usually lower than in the epidermis [25]. Our
previous results demonstrate that in normal oral
epithelia, TA oral keratinocytes are a subpopulation
consisting of approximately 15 % of the total oral kera-
tinocytes [26–29]. Following several rounds of cellular
division, these cells differentiate to post-mitotic keratino-
cytes. Due to their intrinsic attributes, progenitor cells
might be actively involved in regenerating the epithelial
bed following reconstructive surgery or trauma [30–33].
Oral keratinocyte progenitor cells are also known to
replace damaged epithelia with similar traits throughout
the human body. Progenitor cells have been shown to
promote epithelization in animal esophagus, regenerate
human cornea in transplantation procedures [34], act as
adjuvant for treating limbal stem cell deficiencies and
are the elective treatment for urethroplasty procedure
[35, 36]. While several studies focused on the in vitro
and in vivo behavior of oral fibroblasts following gin-
gival augmentation, data on oral keratinocytes is scarce
[37, 38]. A recent in vitro study evaluated cellular func-
tions, such as adhesion, IL-6 production and prolifera-
tion of human gingival keratinocytes cultured on a
newly engineered collagen matrix (CM-10826) and the
assessment of the degree of specific biocompatibility of
this new device [37]. Due to previous difficulties in iso-
lating and characterizing different oral keratinocyte
sub-populations, a thorough analysis of the cellular be-
havior following contact with various oral soft tissue
substitutes is lacking. The hypothesis of the present
study is that the cytological composition of different
populations of keratinocytes does not follow the clinical
and histological healing of the keratinized mucosa aug-
mented with collagen substitutes.
Our group managed to successfully separate and define
several sub-groups of oral keratinocytes, based on two sur-
face markers (integrin alfa6beta4 and CD71), demonstrat-
ing the existence of three separate populations: oral
keratinocyte stem cells (OKSCs), TA cells and post-mitotic
differentiation cells [45–47]. The specific aim of the present
study is to analyze two cell types playing key roles in heal-
ing of oral mucosa following a routine surgical procedure
consisting of placing a resorbable 3D collagen matrix used
for oral soft tissue regeneration. The study will assess the
behavior of different sub-groups of oral keratinocytes and
of inflammatory cells, such as T-lymphocytes, in contact
with the collagen matrix. The study is particularly
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important from a clinical point of view as, on one hand, it
demonstrates disparities between the clinical and histo-
logical aspects of the augmented gingiva, and, on the other
hand, the cytologic level of maturation, as assessed in vitro.
Methods
The study was designed as a pilot study for a harvesting
procedure that simultaneously allows both cell cultures
and histological assessment from gingival biopsies of
very reduced dimensions, in an attempt to minimize any
possible disturbance of the healing process.
Patient selection
Biopsies from three different patients were included in this
study. The subjects were selected from the outpatients of
the Department of Periodontology of the Victor Babes
University of Medicine and Pharmacy of Timisoara,
Romania. They met the following inclusion criteria: at
least 2 but not more than 4 adjacent inferior teeth (up to
the 2nd premolar) with less than 2mm of mucosa that re-
quired augmentation; no need of root coverage at the time
of grafting. The exclusion criteria employed for each pa-
tient were: active periodontal disease, smokers, patients
with history of alcohol abuse, systemic diseases, known
alergies, pregnacies, and acute or chronic infections.
The patients’ background information was as follows:
Patient 1 (Sample 1) - 38 yo, female, biopsy site: teeth
– 3.2–4.3; Patient 2 (Sample 2)–52 yo, female, biopsy
site: teeth 3.3–3.5; Patient 3 (Sample 3)–56 yo, fe-
male, biopsy site: teeth 4.3–4.5.
Clinical procedures
Prior to surgery, demographics, medical and dental his-
tories were collected. An oral examination and profes-
sional cleaning were performed, clinical measurements
were done, x-rays and photographs were taken, oral hy-
giene procedures reviewed and reinforced. Alveolar bone
level and surgical position limits were obtained at base-
line. The first follow-up visit occurred one week post-
surgery and the second visit one week later. At each
visit, biopsies were taken and sent to the cell culture la-
boratory for further analysis. The surgical procedure con-
sisted of placing a fully resorbable 3D collagen matrix
designed for soft tissue regeneration (Geistlich Muco-
graft®, Geistlich Pharma AG, Wolhusen, Switzerland) at
the surgical site using a modification of a well-known
protocol [10, 39]. Briefly, after local anesthesia, a coronal
incision was made at the muco-gingival junction extend-
ing at least to the line angle of the adjacent teeth, and ver-
tical incisions were made at both the mesial and distal
aspects of the grafted sites, so that rectangular wound
beds were slightly larger than the collagen matrix. A
partial-thickness flap was performed, was displaced api-
cally and was sutured with 6-0 resorbable sutures. Muscle
fibers were removed to expose the periosteal bed. The col-
lagen matrix was cut to fit the recipient site, was placed
dry and was sutured in place with single non-resorbable
and resorbable6-0 sutures disposed circumferentially, so
that the matrix soaked with blood would stabilize the clot
over the wound bed. Lips and cheek adjacent to the
grafted sites were put under tension, to ensure there was
no traction on the operated areas. (Figures 1 a-d). Patients
Fig. 1 Images describing the surgical procedure: a) initial situation with deficit of keratinized gingiva; b) mucosal fenestration with apically
positioned flap; c) the collagen matrix sutured in place; d) one week after the surgery; e) ten days after the surgery, immediately after the
removal of the sutures; f) two weeks after the surgery
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were instructed to use chlorhexidine 0.12 % mouth rinse
for 30 s twice daily, to avoid aggressive rinsing or brushing
of the grafted area and hard foods for two weeks after the
surgery. Sutures were removed after ten days. After two
weeks, brushing was resumed using soft brushes and deli-
cate movements to avoid any trauma. Normal brushing
was resumed after six weeks.
Biopsy harvesting procedure
Following a protocol described in the literature [10], bi-
opsies of full-depth mucosa (down to the bone level)
from pristine keratinized gingival areas and newly
formed keratinized gingiva were harvested under local
anesthesia using a 3-mm biopsy punch, prior to surgery,
after 7 and after 14 days, for a different histological
study (data to be published). A part of each sample was
used for cell cultures in the present study, the rest was
used for further detailed histological analysis.
All biopsies were performed from the central zone of
the grafted area under the dental operating microscope
with the aid of microsurgical instruments to avoid any
disturbance of the healing process. To determine the
exact region of harvesting and to avoid harvesting twice
from the same site, preoperative and postoperative pho-
tographs were taken and surgical sketches were drawn.
Specimens were fixed in buffered 4 % formaldehyde and
sent to the histology laboratory. The fixed biopsies were
oriented in a colored-coded biomimetic gel (Biopsy-
Boat™, Themis Pathology SRL, Bucharest, Romania),
post-fixed with formal calcium, dehydrated in graded
ethanols, and embedded in celloidin-parrafin. Semi-
serial sectioning was performed at 5 μm and the result-
ing sections were stained with hematoxilin-eosin (HE).
Immuno-magnetic isolation of oral keratinocyte
progenitor cells
Cell culture protocols and cell separations were per-
formed using a protocol described in detail by Calenic et
al [40, 41]. Briefly, biopsies were rinsed with phosphate
buffer saline at pH 7and subjected to enzymatic dissoci-
ation in Collagenase (Sigma, St. Louis, MO) and Dispase
(Sigma, St. Louis, MO) at 40C overnight. Following pri-
mary culture, the cells were separated using MACS
(Magnetic Activated Cell Sorting, MACS Miltenyi Bio-
tec, Bergisch Gladbach, Germany) and two surface
markers: CD71 and integrin α6β4 (Mouse monoclonal
[450–30A] antibody to Integrin alpha 6 beta 4 (Abcam)
conjugated with Fluorescein isothiocyanate (FITC); goat
anti-mouse IgG MicroBeads and CD71 MicroBeads).
After both separation steps, three cell fractions were ob-
tained: α6β4neg, α6β4pos CD71pos and α6β4 pos
CD71neg fraction. In the present study, we analyzed
α6β4pos CD71pos fraction, which, in our previous stud-
ies, demonstrated important progenitor cells attributes.
The cells were further grown in Petri dishes pre-coated
with human collagen IV (Sigma) (20μg/ml).
Viability of oral keratinocyte progenitor cells
For oral keratinocyte progenitor cells, cellular viability was
assayed using Trypan blue exclusion. Briefly, Trypan blue
stains dead cells in blue; thus the number of dead blue
cells among the total number of cells was counted. For
statistical purposes the assay was performed five times.
Colony forming efficiency of oral keratinocyte progenitor
cells
In order to evaluate colony forming efficiency, 1x104
cells were seeded on type IV-collagen as described
above; after 14 days, the cells were fixed and stained
with crystal violet. Colonies with more than 20 cells
were counted with Cell Analyst (AssaySoft Inc., Fountain
Valley, CA, USA). For statistical purposes the assay was
performed five times.
Immunofluorescence of oral keratinocyte progenitor cells
Immunofluorescence staining techniques followed trad-
itional well-established protocols. Thus, following isola-
tion, the cells were fixed using 4 % paraformaldehyde
and further permeabilized with Triton X 100, followed
by staining using a selection of primary antibodies, and
finally by labeled secondary antibodies (as described in
detail in section Antibody Library). For negative con-
trols, the primary antibody was omitted during the im-
munofluorescence staining procedure. All samples were
further observed under a confocal scanning laser fluor-
escent microscope.
Cell size of oral keratinocyte progenitor cells
Photographs of OKSCs populations were taken using a
light microscope, and the images were analyzed using
Cell Analyst (AssaySoft Inc., Fountain Valley, CA, USA).
The assay was repeated five times, with 20 cells being
counted for each experiment.
Antibody library
For magnetic isolation, the following antibodies were used:
MicroBeads conjugated to anti-human CD71 (Miltenyi Bio-
tec, Inc., Auburn, CA, USA); mouse monoclonal [450-30A]
antibody to integrin a6b4 (Abcam, Germany) and anti-
mouse IgG MicroBeads (Miltenyi Biotec Inc., Auburn, CA,
USA). For immunofluorescence staining the following anti-
bodies were used: mouse monoclonal anti-p63 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA); mouse mono-
clonal anti-cytokeratin (CK) 10 (Acris GmbH, Hertford,
Germany); mouse monoclonal anti-CK14 (Sigma-Aldrich,
Germany). Primary antibodies were diluted at 1: 200. Alexa
Fluor—conjugated donkey anti-mouse (Invitrogen, Eugene,
OR) was used as a secondary antibody. Nuclei staining was
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done with 4′,6-diamidino-2-phenylindole (DAPI) (Invitro-
gen, Eugene, OR, USA).
T Lymphocytes isolation
Samples of 10ml of peripheral venous blood were collected
on anticoagulant [Heparin 15000 IU/5mL, Biochemie
GmbH, Kundl, Austria]. Separation of mononuclear cells
(PBMCs—Peripheral Blood Mononuclear Cells) from
peripheral blood samples was performed by centrifugation
on Ficoll-Paque™ Plus (GE Healthcare Bio-Sciences AB,
Uppsala, Sweden) gradient. After centrifugation, the super-
natant was removed, and the cell pellet was used for in
vitro analysis or frozen at -80 °C and kept for further inves-
tigation. Part of the PBMCs obtained in the previous step
were cultured in order to increase the population of T-
lymphocytes for 48 h in a specific culture medium (T-Cell
expansion Stemline media, Sigma-Aldrich), supplemented
with 10 ml L-Glutamine 200 mM/500 ml medium. After
48 h of in vitro cultivation, the cells were placed in contact
with the 3D collagen matrix (1 x 105 T cells/mm3 collagen
matrix) and transferred to 24-well plates. The com-
parative analysis was performed between the cells in
contact with the 3D collagen matrix and the control-
group cells.
T Lymphocytes viability
For the determination of induction and apoptotic execu-
tion propensity, the Annexin-V/PI method was used. In
order to distinguish apoptotic cells from cells with
permeabilized plasma membrane during the late non-
apoptotic death, a viability marker (propidium iodide)
was used, so that only apoptotic cells appeared positive
for annexin V, and double-positive cells (annexin V+
iodide Propidium+) were eliminated.
Immunophenotyping analysis of T-cells by flow-cytometry
Lymphocyte immunophenotyping analysis was carried
out both for lymphocytes cultured in the main culture
medium, as well as for lymphocytes which have been in
contact with the collagen matrix for 5 days. Surface
markers were evaluated by flow cytometry after prepar-
ing the cells for this purpose. The cells, with a 105 cells/
ml concentration, were washed in PBS, resuspended in
PBS and incubated for 30 min in the dark with
fluorochrome-conjugated monoclonal antibodies using
the manufacturers recommended dilutions. After wash-
ing with a dedicated solution (Cell Wash Solution, BD
Biosciences, San Jose, CA, USA), the cells were resus-
pended in 500 μl Cell Wash and analyzed with a FACS-
Calibur flowcytometer (BD Biosciences, San Jose, CA,
USA). Data acquisition was performed using the pro-
gram CellQuest Pro software (BD Biosciences, San Jose,
CA, USA), and data analysis using the free flow cytome-
try data analysis Flowing Software 2.5.
Statistical analysis
For the oral keratinocytes in vitro behaviour, results
from five independent experiments are shown as means
± SD. For each independent experiment, the same num-
ber of cells was used. Statistical analysis was performed
using Student’s t-test. Statistical significance was ac-
cepted at p < 0.05. For T-lymphocytes data, Student’s t-
test was employed for all data.
Results
The healing occurred uneventfully in all patients. At
seven days after the surgery, the recipient site ap-
peared still covered with a fibrin-like layer of fragile
aspect, with several areas of flat granulation appear-
ance (Fig. 1d). At 14 days after the surgery, the
recipient site displayed a macroscopical aspect of
complete healing (Fig. 1f ).
Oral keratinocyte progenitor cells
Cell count following magnetic separation demonstrated
that, as opposed to normal oral mucosa, at both 7 and
14 days, most of the cells (over 90 %) were found to have
the alfa6beta4 + CD71+ phenotype, which identifies the
oral keratinocyte progenitor cells subgroup.
Cell viability
The data represent the percentage of viable oral kera-
tinocyte progenitor cells for various samples at different
time points: 0, 7 and 14 days. At each analyzed point in
time, most cells were found to be viable, as follows:
Sample 1–95.2 ± 1.2 vs. 93.2 ± 2.2 vs. 96.2 ± 0.2; Sample
2–96.2 ± 2.3 vs. 91.2 ± 1.2 vs. 93.1 ± 3.1; Sample 3–97.6
± 0.6 vs. 90.5 ± 0.5 vs. 94.5 ± 2.5 for 0, 7 and 14 days, re-
spectively (n = 5, p <0.05 Student’s t-test) (Fig. 2).
Colony forming efficiency
Colony forming efficiency was analyzed at 0, 7 and 14
days for each sample and the data represent the number
of CFUs, as follows: Sample 1–194 ± 14 vs. 144 ± 4 vs.
178 ± 8; Sample 2–201 ± 15 vs. 125 ± 5 vs. 189 ± 9; Sam-
ple 3–183 ± 13 vs. 123 ± 12 vs. 180 ± 10 for each time
point respectively (n = 5, p<0.05 Student’s t-test) (Fig. 3).
Cell size
Following biopsies at different time points, the oral
keratinocyte progenitor cells were assayed for their
cell size. After 0, 7 and 14 days, the percentage of
cells displaying the same size as the oral keratinocyte
progenitor cells from pristine sites was calculated:
Sample 1–100 vs. 68 ± 8.2 vs. 84 ± 4.3; Sample 2–100
vs. 75 ± 5.2 vs. 81 ± 5.1; Sample 3–100 vs. 73 ± 3.1 vs.
79 ± 2.7 for each sample and time point respectively
(n = 5, p<0.05 Student’s t-test) (Fig. 4).
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Immunofluorescence
After 14 days of in vitro culture, actively amplifying cells
were characterized by immunostaining using three
markers: a keratinocyte stem cell marker - p63; CK14
for basal layer and CK10 for upper layer. In all analyzed
samples, our selected keratinocyte subpopulation stained
negative for p63 and weakly positive for CK10 and posi-
tive for CK14, as shown in Fig. 5.
Lymphocyte assessment
As shown in Table 1, T-lymphocytes expressed similar
viability levels in both the control groups (cells analyzed
immediately after isolation) and in stimulated cells. At
the same time flow cytometry was used for characteriz-
ing lymphocyte cells for specific markers. Results (pre-
sented in Table 2) show different distributions of CD8+,
CD4+, CD69, CD34 or CD25 T cells after 5 days of
lymphocyte exposure to the collagen matrix.
Discussion
Oral keratinocytes and their behaviour on contact with
artificial biomaterials used for oral soft tissue regener-
ation have not been thoroughly studied; however, several
experimental studies focused in the past on human
Fig. 3 Colony forming efficiency. Graph representing the colony forming potential of α6β4+/CD71+ cells at baseline, 7 and 14 days, respectively
(number of CFUs). Following magnetic separation, cells were stained with crystal violet; colonies larger than 20 cells were counted individually
using an image software (each sample identifies different individuals; n = 5, p <0.05 Student’s t-test)
Fig. 2 Cell viability. Graph representing the percentage of α6β4+/CD71+ cells cells at different time points: 0, 7 and 14 days. At each analyzed time
point most cells were found viable in all analyzed samples, with rare necrosis (each sample identifies different individuals; n = 5, p <0.05 Student’s t-test)
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keratinocytes cultivated on dermal substitutes. Tinois et
al. [42] showed that a construct consisting in a type I +
III collagen supporting a type IV collagen layer offers an
excellent substrate for keratinocytes, favors their anchor-
age, and favors the formation of the basement mem-
brane in vitro. Other studies aimed at designing tailored
biomaterial surfaces to direct keratinocyte morphology,
attachment, and differentiation. These features can be
incorporated into dermal equivalents and percutaneous
implants to enhance the rate of reepithelialization and
tissue regeneration [43]. In a similar experimental
approach, the generation of site-appropriate tissue in the
treatment of mucogingival defects was attempted by cul-
tivating allogeneic cultured keratinocytes and fibroblasts
in a living cellular sheet of bovine collagen, which re-
sulted in the generation of tissue that was more site-
appropriate than that transplanted from the palate [44].
To our knowledge, this is the first study on the early
healing process after gingival augmentation using colla-
gen soft tissue substitutes, to simultaneously assess the
behavior of the cells at the surface and the T-lymphocyte
response, with additional confirmatory biopsies.
Fig. 4 Cell size. Graph representing the percentage of α6β4+/CD71+ cells displaying the same size as the α6β4pos CD71pos oral keratinocyte
progenitor cells from pristine sites (each sample identifies different individuals; n = 5, p <0.05 Student’s t-test)
Fig. 5 Immunofluorescence. Oral keratinocyte progenitor cells at 14 days expressed different stem- and differentiation markers (nuclei stained with
DAPI); original magnification (x40). p63 - a specific oral keratinocyte stem cells marker; CK14 - differentiation marker usually positive for keratinocytes
found in the basal layers of the epithelia; CK10 - differentiation marker expressed on cells found in the upper layers of the oral epithelia
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In the present study, we have analyzed several sub-
populations of oral keratinocyte cells, isolated with a pre-
viously established protocol by our group [40, 45]. We
used two cell surface markers: integrin alfa6beta4 and a
proliferation related marker CD71 to isolate three cellular
subgroups: integrin alfa6beta4- or the postmitotic differ-
entiation cells, integrin alfa6beta4 + CD71- which repre-
sented the oral keratinocyte stem cells population and
integrin alfa6beta4 + CD71+ identified as TA cells or pro-
genitor cells. Following placement of a 3D resorbable col-
lagen membrane, at different time points (i.e. before
surgery, one week after surgery and two weeks after sur-
gery) we have collected biopsies and isolated and charac-
terized the cellular populations present at the site.
Following immunofluorescence staining with different
stem- and differentiation markers, we concluded that after
7 days and 14 days the majority of cells that repopulate
the matrix were actively proliferating cells or progenitor
cells with the phenotype integrin alfa6beta4 + CD71+. The
relative lower number of oral keratinocyte stem cells as
well as postmitotic differentiation cells, compared to the
controls (i.e. pre-operative surgery), can be explained by
the fact that progenitor cells are among the first ones that
migrate and populate the new healing sites; it must also
be noted that our analysis included only a short term as-
sessment of the newly formed mucosa, at 7 and 14 days.
Cellular viability analysis showed that both at 7 and
14 days, most of the cells were viable (over 90 % of the
total group) without any statistical differences between
the analyzed groups (Fig. 2). This shows that in all cases
the interaction between the collagen matrix and the
keratinocytes was not cytotoxic and that the matrix
does not have negative effects on different keratinocyte
sub-populations. The proliferative potential of oral
keratinocyte progenitor cells was analyzed after plating
the cells in culture for 14 days and analyzing their col-
ony forming efficiency (Fig. 3). Consistent with our pre-
vious studies, integrin alfa6beta4 + CD71+ cells were
found in an actively proliferating state, especially after
14 days, and formed a statistically comparable number
of colonies with the progenitor cells isolated prior to
the surgical intervention. In all analyzed samples, TA
cells showed less colony forming potential when iso-
lated at 7 days after surgery; we can speculate that these
cells need at least one week in order to re-gain their
initial colony-forming potential. Our data are consistent
with the hypothesis that TA cells are the group respon-
sible with generating the bulk of the keratinocyte pool
during the healing process. Another test focused on
assaying cellular sizes at both one week and two weeks,
and compared the results with the initial pre-operatory
assessment (Fig. 4). Our results demonstrate that, espe-
cially after two weeks, integrin alfa6beta4 + CD71+ cells
showed a similar cell size with the cells analyzed prior
to surgery from pristine sites. Thus, in all samples an
average of 80% of the cells had the same size with the
ones analyzed in the initial biopsy. Immunofluores-
cence staining demonstrated that most cells represent
progenitor keratinocytes, staining weakly positive for
CK10, intensely positive for CK14 and negative for p63
(Fig. 5) [46–48]. p63 is a well established keratinocyte
stem cell marker, CK14 is usually characteristic to cells
found only in the supra-basal layers (such as TA cells)
while CK10 is found on keratinocytes residing in the
upper layers such as post-mitotic differentiating cells.
Taken together, our immunostaining findings suggest
that most cells populating the resorbable collagen
MATRIX are actively proliferating cells (TA cells)
normally found only in the supra-basal layers of the
epithelia.
Table 1 Lymphocytes viability (in percentages) following Annexin V staining at 14 days
Sample 1 control Sample 1 + collagen Sample 2 control Sample 2 + collagen Sample 3 control Sample 3 + collagen
Viable cells 95.6 ± 1.2 95.7 ± 0.4 90.1 ± 2.1 88.6 ± 2.4 76.5 ± 4.3 77.3 ± 2.2
Necrotic cells 4.0 ± 0.2 3.9 ± 1.1 9.8 ± 1.4 11.2 ± 2.1 23.3 ± 4.3 22.4 ± 4.2
The results show that most analyzed immune cells are viable for each analyzed sample, with very few necrotic cells
Table 2 Flow cytometry analysis of lymphocyte cell type: cellular group and the percentage of cells found both in control group
and after 5 days seeding on the collagen matrix
Sample 1 control Sample 1 + collagen Sample 2 control Sample 2 + collagen Sample 3 control Sample 3 + collagen
Limphocytes T 18.3 ± 2.1 19.0 ± 3.1 65.6 ± 4.3 66.6 ± 2.1 29.6 ± 5.2 40.3 ± 2.7
Non-T cells 39.5 ± 4.6 12.2 ± 0.2 26.86 ± 2.1 21.4 ± 1.3 27.1 ± 4.7 36.7 ± 6.5
T CD8+ 49.1 ± 4.3 57.9 ± 6.5 2.64 ± 0.2 2.88 ± 1.1 12.5 ± 3.7 12.8 ± 2.6
T CD4+ 13.2 ± 1.2 18.8 ± 3.3 1.83 ± 0.3 1.21 ± 0.3 12.5 ± 1.6 4.0 ± 1.7
CD38 93.8 ± 4.3 94.8 ± 1.2 8.4 ± 4.5 4.8 ± 0.9 53.1 ± 3.3 48.5 ± 3.4
CD69 72.2 ± 3.4 79.0 ± 2.7 5.4 ± 1.5 1.7 ± 0.1 1.1 ± 0.2 8.9 ± 2.3
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A challenge of the present study was the reduced di-
mensions of the biopsies and the fragility of the tissues;
the separation between the part of the sample destined
to histology and the part destined to cell cultures was
extremely difficult, even using microsurgical instruments
and magnifications.
An ethical concern could be raised regarding the po-
tential influence of the harvesting of the biopsies on the
healing process. Human biopsies to evaluate the healing
after gingival augmentation procedures using autologous
or artificial grafts are repeatedly described in the litera-
ture [7, 10, 39]. While one of the mentioned studies de-
scribes unproblematic harvesting at 1, 2, 3, 4, 6 and 10
weeks after the surgery from the same surgical site [7],
the procedure used in the present study uses biopsies
taken with utmost care under microsurgical conditions
at 1 and two weeks. As demonstrated before the Com-
mission on Research Ethics, the decision on this proced-
ure was taken based on a long surgical experience of the
authors and multiple observations of the post-surgical
healing process. On the other hand, biopsies of pristine
keratinized gingiva were absolutely necessary forthe
study’s target comparisons. The observations show that
healing after such particular small-dimension biopsies is
uneventful, induces no unnecessary suffering for the pa-
tient and leave absolutely no trace.
At the same time, histological findings show at base-
line normal keratinized gingiva with the well-known
mature tissue architecture (Fig. 6a); Fig. 6b displays an
incompletely formed keratinized gingiva at 7 days post
intervention: the basal third layers of the epithelia are
not completely organized while the underlying connect-
ive tissue is still regenerating. However, 14 days after
the procedure H&E staining demonstrates an oral epi-
thelia that is normally organized with formation of rete
ridges and keratinized upper layers, hard to differenti-
ate from the architecture of pristine keratinized gingiva
(Fig. 6c).
Another important cell population analyzed for the
first time in the present study in relation to its behavior
towards the 3D collagen matrix is the T-lymphocytes
sub-population, involved in the cell-mediated immun-
ity. Our aim was to assess if the collagen matrix im-
pedes viability, and to characterize this specific cell
population for different markers (Table 2). We have an-
alyzed unstimulated T-cells (taken from each patient
prior to any surgical intervention) and the same T-cells
after culturing them in contact with the collagen matrix
for 5 days. The data show that CD8 + T-cells (cytotoxic)
increased in number after exposure to the collagen
matrix, when compared to matched controls. These re-
sults are consistent for all patients included in this
study. At the same time, CD4+ T cells decreased, prob-
ably as a compensatory mechanism for the citotoxic
lymphocytes [49]. CD69 was found to increase in the T-
cells adjacent to the collagen matrix; this marker is
known to be activated early in the immune response
[50]. CD38 data was not consistent for all analyzed
samples, but it displayed a statistically non-significant
decrease in the immune cells exposed to collagen [50].
At the same time, CD25 was absent in all samples, con-
sistent with other studies that showed that this marker
is activated later during the immune response [51]. At
the same time, Annexin V staining showed that the per-
centage of viable lymphocytes was consistent bewteen
the control group and the cells exposed to the collagen
membrane for each patient, respectively (As shown in
Table 1). Data on white blood cells (as presented in
Table 2) demonstrates the interpersonal variations in
lymphocyte composition (T and non-T lymphocytes, CD8
+, CD4+, CD38 and CD69). The differences in T cells
composition for patient 1 (Sample 1) may be related to in-
dividual characteristics such as age.
One important limitation of the present work is the
reduced number of patients and the oral tissue har-
vesting method, which is currently technique-sensitive
Fig. 6 Oral mucosa and collagen matrix. Oral tissue samples before the procedure (a)(HE, x10), one week (b)(HE, x40) and 2 weeks after the
procedure (c)(HE, x40). Histological assessment shows that 7 days following surgery, the oral epithelia is still forming, while at 14 days the
architecture closely resembles the pristine gingiva (Scale bar - 100μm)
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and needs further standardization and improvement.
Further studies are needed in order to elucidate these
issues.
Conclusion
In vitro assessment of different oral keratinocyte sub-
populations at 14 days after placing a 3d collagen matrix
for augmentation of the keratinized gingiva, with a focus
on progenitor cells, supports the claim that maturation
of cytologic composition might take more than two
weeks, while clinical aspect and histological analysis at
the same timepoint demonstrate a mature epithelial
architecture. At the same time, the T-lymphocytes re-
sponse induced by the matrix does not seem to hinder
the healing process. However, more long-term studies
are needed in order to better analyze the cellular popula-
tions involved in regenerating the oral mucosa.
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